These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21941414)

  • 1. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.
    Mirici-Cappa F; Caraceni P; Domenicali M; Gelonesi E; Benazzi B; Zaccherini G; Trevisani F; Puggioli C; Bernardi M
    World J Gastroenterol; 2011 Aug; 17(30):3479-86. PubMed ID: 21941414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
    ;
    Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites.
    Borges de Santana V; Bertocco de Paiva Haddad L; Morgado Conte T; Cortez Rizzon A; Miranda Barbosa V; Shield W; Andraus W; Augusto Carneiro D'Albuquerque L
    Transplant Proc; 2014; 46(6):1760-3. PubMed ID: 25131030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin for cirrhosis-related complications.
    Erstad BL
    J Clin Pharm Ther; 2021 Aug; 46(4):887-894. PubMed ID: 34101215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoalbuminemia.
    Gatta A; Verardo A; Bolognesi M
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S193-9. PubMed ID: 23073857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical indications for the albumin use: still a controversial issue.
    Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
    Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
    Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
    Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
    Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
    J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [When should we give albumin in patients with cirrhosis?].
    Bochatay L; Elkrief L; Spahr L
    Rev Med Suisse; 2015 Sep; 11(484):1596, 1598-601. PubMed ID: 26502620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current indications for the use of albumin in the treatment of cirrhosis.
    Alves de Mattos A
    Ann Hepatol; 2011 May; 10 Suppl 1():S15-20. PubMed ID: 21566250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
    Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
    Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.
    Caraceni P; Angeli P; Prati D; Bernardi M; ; Liumbruno GM; Bennardello F; Piccoli P; Velati C;
    Blood Transfus; 2016 Jan; 14(1):8-22. PubMed ID: 26820615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [News for usage of albumin in patients with liver disease].
    Cremonese C; Uschner FE; Trebicka J
    Dtsch Med Wochenschr; 2020 Jun; 145(11):722-726. PubMed ID: 32492740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of albumin in the treatment of decompensated liver cirrhosis.
    Trebicka J
    Curr Opin Gastroenterol; 2022 May; 38(3):200-205. PubMed ID: 35275900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
    Yosry A; Soliman ZA; Eletreby R; Hamza I; Ismail A; Elkady MA
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):345-351. PubMed ID: 30312183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin: Indications in chronic liver disease.
    Tufoni M; Zaccherini G; Caraceni P; Bernardi M
    United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.